Subscribe to our newsletter to receive the latest product updates and special offers

Upgrade to FINVIZ*Elite to get real-time quotes, intraday charts, and advanced charting tools.

Last Close
Jul 19 04:00PM ET
Dollar change
Percentage change
Index- P/E- EPS (ttm)-0.76 Insider Own15.99% Shs Outstand61.45M Perf Week3.74%
Market Cap68.21M Forward P/E- EPS next Y-0.67 Insider Trans20.56% Shs Float51.62M Perf Month75.27%
Income-32.44M PEG- EPS next Q-0.15 Inst Own12.87% Short Float7.61% Perf Quarter109.08%
Sales0.01M P/S6820.95 EPS this Y-2.53% Inst Trans-27.27% Short Ratio4.03 Perf Half Y-30.19%
Book/sh0.04 P/B28.94 EPS next Y0.99% ROA-116.94% Short Interest3.93M Perf Year-52.36%
Cash/sh0.13 P/C8.55 EPS next 5Y- ROE-368.02% 52W Range0.50 - 2.57 Perf YTD-46.63%
Dividend Est.- P/FCF- EPS past 5Y18.26% ROI-333.88% 52W High-56.81% Beta1.76
Dividend TTM- Quick Ratio0.61 Sales past 5Y100.00% Gross Margin-13651.59% 52W Low121.56% ATR (14)0.11
Dividend Ex-Date- Current Ratio0.83 EPS Y/Y TTM-1.25% Oper. Margin-321348.91% RSI (14)66.39 Volatility12.85% 12.05%
Employees57 Debt/Eq9.15 Sales Y/Y TTM-99.99% Profit Margin-369519.72% Recom1.00 Target Price9.00
Option/ShortYes / Yes LT Debt/Eq4.34 EPS Q/Q-52.80% Payout- Rel Volume0.64 Prev Close1.17
Sales Surprise-99.30% EPS Surprise-2.22% Sales Q/Q- EarningsMay 15 AMC Avg Volume974.49K Price1.11
SMA2030.35% SMA5040.29% SMA200-12.85% Trades Volume636,806 Change-5.13%
Date Action Analyst Rating Change Price Target Change
Mar-01-21Initiated Northland Capital Outperform $10
Feb-03-20Downgrade Oppenheimer Outperform → Perform
Jul-01-24 06:50AM
Jun-28-24 08:00AM
May-23-24 06:00AM
May-20-24 12:00PM
May-16-24 03:07AM
08:55PM Loading…
May-15-24 08:55PM
May-14-24 07:00AM
May-10-24 06:31AM
Apr-25-24 07:00AM
Apr-09-24 09:29AM
Apr-08-24 07:00AM
Apr-03-24 07:00AM
Mar-27-24 11:28AM
08:50AM Loading…
Mar-19-24 08:50AM
Mar-18-24 08:53PM
Mar-13-24 07:00AM
Mar-11-24 07:00AM
Mar-05-24 12:59PM
Mar-04-24 06:21PM
Feb-13-24 07:00AM
Jan-26-24 09:22AM
Jan-16-24 07:00AM
Dec-15-23 08:17AM
10:38AM Loading…
Nov-14-23 10:38AM
Nov-13-23 04:05PM
Nov-06-23 08:00AM
Nov-02-23 07:00AM
Oct-30-23 03:52PM
Oct-09-23 07:00AM
Sep-21-23 08:00AM
Sep-07-23 08:00AM
Aug-24-23 06:47PM
Aug-16-23 06:00AM
Aug-14-23 09:05AM
Aug-11-23 06:08AM
Aug-10-23 04:05PM
Aug-09-23 08:00AM
Aug-07-23 08:00AM
Aug-03-23 08:00AM
Jun-26-23 08:00AM
Jun-06-23 09:00AM
Jun-01-23 08:00AM
May-12-23 06:04AM
May-11-23 04:05PM
May-08-23 04:39PM
May-04-23 08:00AM
Apr-24-23 08:00AM
Apr-05-23 07:46PM
Mar-30-23 04:05PM
Mar-23-23 08:00AM
Feb-28-23 04:05PM
Feb-22-23 06:08AM
Feb-15-23 09:51AM
Jan-12-23 12:47PM
Dec-20-22 08:00AM
Dec-13-22 08:00AM
Dec-08-22 08:00AM
Nov-29-22 08:00AM
Nov-23-22 04:05PM
Nov-13-22 07:04AM
Nov-10-22 04:05PM
Nov-03-22 08:00AM
Oct-21-22 08:00AM
Oct-20-22 08:00AM
Oct-05-22 02:50PM
Sep-30-22 08:00AM
Sep-07-22 08:00AM
Sep-06-22 08:00AM
Aug-10-22 04:05PM
Aug-04-22 08:00AM
Jul-27-22 08:00AM
Jul-18-22 08:00AM
Jul-07-22 08:00AM
Jul-06-22 08:00AM
Jun-29-22 08:53AM
Jun-09-22 10:09AM
Jun-07-22 08:00AM
May-15-22 08:06AM
May-12-22 04:05PM
May-05-22 08:00AM
Apr-20-22 08:00AM
Apr-19-22 08:00AM
Apr-03-22 01:46PM
Mar-31-22 01:17PM
Mar-28-22 04:05PM
Mar-21-22 08:00AM
Eyenovia, Inc. is a clinical stage biopharmaceutical company, which engages in the research and development of ophthalmology products. The company offers a piezo-print technology to deliver micro-doses of micro-therapeutics for the eyes. Its products include MicroProst, MicroStat, MicroTears, and MicroPine. The firm is currently focused on the late-stage development of microdosed medications for presbyopia, myopia progression, and mydriasis. The company was founded by Sean Ianchulev on March 12, 2014 and is headquartered in New York, NY.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
Grant Stuart M.10% OwnerJul 02 '24Buy0.661,515,1511,000,00010,914,153Jul 03 03:18 PM
Grant Stuart M.10% OwnerMar 28 '24Buy0.98100,00098,0005,430,715Mar 28 03:50 PM
Grant Stuart M.10% OwnerMar 19 '24Buy1.2350,00061,5005,330,715Mar 20 05:44 PM
Grant Stuart M.10% OwnerMar 08 '24Buy1.5810,71716,9115,280,715Mar 11 08:11 AM
Rowe Michael MChief Executive OfficerDec 04 '23Buy1.364,8906,65032,927Dec 05 04:54 PM
Strahlman Ellen RDirectorSep 29 '23Buy1.684,8208,09875,113Oct 02 10:04 AM
Rowe Michael MChief Executive OfficerSep 19 '23Buy1.661,4002,32428,037Sep 19 05:17 PM
Rowe Michael MChief Executive OfficerSep 15 '23Buy1.751,1371,99026,637Sep 19 05:17 PM
Grant Stuart M.10% OwnerAug 17 '23Buy1.8730,00056,1005,269,998Aug 17 03:16 PM
Grant Stuart M.10% OwnerAug 16 '23Buy1.9145,00085,8155,239,998Aug 17 03:16 PM